Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Monogram Orthopaedics Inc ( (MGRM) ) just unveiled an announcement.
On August 29, 2025, Monogram Technologies Inc. informed its stockholders about a special meeting scheduled for September 30, 2025, to approve its acquisition by Zimmer Biomet Holdings, Inc., initially announced on July 14, 2025. This acquisition is a significant move for Monogram Technologies, potentially impacting its operations and market positioning, as it seeks shareholder approval to finalize the deal.
The most recent analyst rating on (MGRM) stock is a Buy with a $10.80 price target. To see the full list of analyst forecasts on Monogram Orthopaedics Inc stock, see the MGRM Stock Forecast page.
Spark’s Take on MGRM Stock
According to Spark, TipRanks’ AI Analyst, MGRM is a Neutral.
Monogram Orthopaedics Inc. shows promise due to significant technological advancements and recent regulatory clearances, which are key drivers for potential growth. However, financial instability, regulatory uncertainties, and ongoing profitability challenges weigh heavily on the overall score. The stock’s upward momentum is a positive indicator, but valuation metrics remain weak due to negative earnings and lack of dividends.
To see Spark’s full report on MGRM stock, click here.
More about Monogram Orthopaedics Inc
Average Trading Volume: 366,813
Technical Sentiment Signal: Buy
See more data about MGRM stock on TipRanks’ Stock Analysis page.